pyrroles has been researched along with pd 173074 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doherty, P; Facci, L; Kee, WJ; Macdonald, G; Skaper, SD; Walsh, FS | 1 |
| Chase, AJ; Cross, NC; Grand, EK; Heath, C; Rahemtulla, A | 1 |
| Boonyarat, C; Grierson, DS; Kammasud, N; Saiki, I; Sakurai, H; Tsunoda, S; Vajragupta, O | 1 |
| Bachmann, AW; Hutley, LJ; Newell, FS; Prins, JB; Ramnoruth, SN; Spelta, MC; Whitehead, JP; Widberg, CH | 1 |
| Chester, JD; Cooper, PA; Knowles, MA; Lamont, FR; Shnyder, SD; Tomlinson, DC | 1 |
| Batey, MA; de Brito, LR; Hall, AG; Irving, JA; Jackson, G; Leung, HY; Maitland, H; Newell, DR; Squires, MS; Zhao, Y | 1 |
| Akita, K; Fujii, I; Gouda, M; Ishihama, Y; Kirii, Y; Kitagawa, D; Narumi, Y; Sugiyama, N; Yokota, K | 1 |
| Ealy, AD; Zhang, K | 1 |
| Balek, L; Buchtova, M; Dosedelova, H; Gudernova, I; Jelinkova, I; Kozubik, A; Krejci, P; Kunova, M; Pivnicka, J; Roubalova, L; Vesela, I | 1 |
9 other study(ies) available for pyrroles and pd 173074
| Article | Year |
|---|---|
The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Survival; Cells, Cultured; Chick Embryo; Ciliary Neurotrophic Factor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblast Growth Factor 2; Glial Cell Line-Derived Neurotrophic Factor; Insulin-Like Growth Factor I; Mitogen-Activated Protein Kinases; Nerve Growth Factor; Nerve Growth Factors; Nerve Tissue Proteins; Neurites; Neurons; PC12 Cells; Phosphorylation; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Sensitivity and Specificity | 2000 |
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.
Topics: Cell Line, Tumor; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 4; Humans; Multiple Myeloma; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Fibroblast Growth Factor; Translocation, Genetic | 2004 |
Novel inhibitor for fibroblast growth factor receptor tyrosine kinase.
Topics: Chemistry, Pharmaceutical; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Fibroblast Growth Factor 1; Humans; Hydrogen Bonding; Indoles; JNK Mitogen-Activated Protein Kinases; Lysine; Models, Chemical; Molecular Conformation; Oxindoles; Propionates; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1 | 2007 |
Fibroblast growth factor receptor 1 is a key regulator of early adipogenic events in human preadipocytes.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adult; Aged; Becaplermin; Cell Growth Processes; Female; Fibroblast Growth Factor 1; Humans; Male; Middle Aged; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2009 |
Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo.
Topics: Animals; Apoptosis; Benzimidazoles; Blotting, Western; Carcinoma, Transitional Cell; Cell Cycle; Cell Proliferation; Cells, Cultured; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mutation; Phosphorylation; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 3; Urinary Bladder Neoplasms; Urothelium; Xenograft Model Antitumor Assays | 2011 |
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Indoles; Mice; Mice, Inbred BALB C; Mice, Nude; Multiple Myeloma; Phthalazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptor Protein-Tyrosine Kinases; Sunitinib; Xenograft Model Antitumor Assays | 2011 |
Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase.
Topics: Animals; Benzamides; Benzenesulfonates; Binding, Competitive; Cell Line; Dasatinib; Dose-Response Relationship, Drug; Humans; Imatinib Mesylate; Indazoles; Indoles; Kinetics; Niacinamide; Phenylurea Compounds; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Sorafenib; Spodoptera; Staurosporine; Sulfonamides; Sunitinib; Surface Plasmon Resonance; Thiazoles; Transfection | 2012 |
Disruption of fibroblast growth factor receptor signaling in bovine cumulus-oocyte complexes during in vitro maturation reduces subsequent embryonic development.
Topics: Animals; Cattle; Cumulus Cells; Embryonic Development; Female; Fertilization in Vitro; Oocytes; Pregnancy; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Real-Time Polymerase Chain Reaction; Receptors, Fibroblast Growth Factor; RNA; Signal Transduction | 2012 |
Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
Topics: Achondroplasia; Animals; Benzamides; Cartilage; Catalysis; Cells, Cultured; Chick Embryo; Chondrocytes; Humans; Mice; Phenylurea Compounds; Piperazines; Pyrazoles; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Signal Transduction; Syndrome | 2016 |